Free Trial

Biohaven (BHVN) Stock Price, News & Analysis

Biohaven logo
$15.47 +0.65 (+4.39%)
Closing price 10/2/2025 03:59 PM Eastern
Extended Trading
$15.69 +0.22 (+1.42%)
As of 10/2/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biohaven Stock (NYSE:BHVN)

Advanced

Key Stats

Today's Range
$14.81
$15.53
50-Day Range
$12.81
$16.21
52-Week Range
$12.79
$55.70
Volume
1.59 million shs
Average Volume
2.57 million shs
Market Capitalization
$1.64 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.85
Consensus Rating
Buy

Company Overview

Biohaven Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

BHVN MarketRank™: 

Biohaven scored higher than 67% of companies evaluated by MarketBeat, and ranked 373rd out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biohaven has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Biohaven has a consensus price target of $48.85, representing about 215.7% upside from its current price of $15.47.

  • Amount of Analyst Coverage

    Biohaven has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Biohaven's stock forecast and price target.
  • Earnings Growth

    Earnings for Biohaven are expected to grow in the coming year, from ($8.90) to ($6.28) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biohaven is -2.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biohaven is -2.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biohaven has a P/B Ratio of 3.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Biohaven's valuation and earnings.
  • Percentage of Shares Shorted

    12.47% of the outstanding shares of Biohaven have been sold short.
  • Short Interest Ratio / Days to Cover

    Biohaven has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Biohaven has recently increased by 23.85%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Biohaven does not currently pay a dividend.

  • Dividend Growth

    Biohaven does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.47% of the outstanding shares of Biohaven have been sold short.
  • Short Interest Ratio / Days to Cover

    Biohaven has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Biohaven has recently increased by 23.85%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Biohaven has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Biohaven this week, compared to 18 articles on an average week.
  • Search Interest

    191 people have searched for BHVN on MarketBeat in the last 30 days. This is an increase of 247% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Biohaven to their MarketBeat watchlist in the last 30 days. This is an increase of 13% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biohaven insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    16.00% of the stock of Biohaven is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    88.78% of the stock of Biohaven is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Biohaven's insider trading history.
Receive BHVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biohaven and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BHVN Stock News Headlines

An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
See More Headlines

BHVN Stock Analysis - Frequently Asked Questions

Biohaven's stock was trading at $37.35 on January 1st, 2025. Since then, BHVN shares have decreased by 58.6% and is now trading at $15.4710.

Biohaven Ltd. (NYSE:BHVN) issued its earnings results on Monday, August, 11th. The company reported ($1.94) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($1.94).

Biohaven (BHVN) raised $124 million in an IPO on Thursday, May 4th 2017. The company issued 8,300,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, Piper Jaffray and Barclays Capital served as the underwriters for the IPO and William Blair and Needham & Company were co-managers.

Shares of BHVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biohaven investors own include NVIDIA (NVDA), Humana (HUM), Invesco QQQ (QQQ), Meta Platforms (META), American Water Works (AWK), Broadcom (AVGO) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/11/2025
Today
10/02/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:BHVN
Previous Symbol
NASDAQ:BHVN
CIK
1935979
Fax
N/A
Employees
239
Year Founded
2014

Price Target and Rating

High Price Target
$75.00
Low Price Target
$21.00
Potential Upside/Downside
+215.7%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($7.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$846.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-270.65%
Return on Assets
-143.70%

Debt

Debt-to-Equity Ratio
1.91
Current Ratio
3.82
Quick Ratio
3.82

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
3.69

Miscellaneous

Outstanding Shares
105,790,000
Free Float
88,864,000
Market Cap
$1.64 billion
Optionable
Optionable
Beta
1.03

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:BHVN) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners